Support
Home
About
Tools
FAQ
Help Desk
Testimonials
Affiliates
Signup
Login
Signup
Login
Biogen Stock Halted Pending FDA Decision On Alzheimer's Treatment
Biogen stock was halted Friday ahead of an FDA decision on the accelerated approval of its experimental Alzheimer's treatment, lecanemab.
Click Here To Get Funded!